Literature DB >> 25693780

[Aortofemoral vascular graft infections and their prevention].

F Taher1, O Assadian, K Hirsch, J Falkensammer, C Senekowitsch, A Assadian.   

Abstract

Vascular prosthesis infections are potentially severe adverse events following vascular reconstruction. They are often associated with a high morbidity and mortality, especially in the aortofemoral region. The present article outlines the diagnosis, prevention and treatment of vascular graft infections in a clinical setting. The clinical presentation, inflammatory markers, microbiological work-up and imaging studies can contribute to diagnosing a prosthesis infection. Regarding the bacterial spectrum involved in the etiology of prosthesis infections, single organism infections (monoinfections) have become less significant over the past years, whereas infections with multiple organisms now constitute the most abundant microbiological constellation. Also, infections with resistant bacterial strains have been increasing in number over the past years and deserve special consideration. It remains unclear whether both aspects are due to a true epidemiological change or are the result of advanced molecular microbiological diagnostic methods. While during the past decades perioperative antibiotic prophylaxis was regarded as the most important measure for preventing prosthesis infections in vascular surgery, other primary preventive hygiene strategies have been increasingly explored and grouped together in the sense of preventive bundles. In most cases of deep postoperative infections involving a prosthetic device in the aortofemoral region, explantation of the prosthesis will be required. In situ and extra-anatomical reconstructions are often performed in such cases and the decision process to develop an optimal treatment plan must consider several individual factors. In select patients, palliative preservation of the prosthesis despite surrounding infection (i.e. graft salvage) and best conservative management in combination with local surgical measures, such as incision and drainage and vacuum therapy, deserve consideration as a treatment option for patients with a high surgical risk.

Entities:  

Mesh:

Year:  2015        PMID: 25693780     DOI: 10.1007/s00104-015-3009-x

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  23 in total

Review 1.  The current role of rifampicin-impregnated grafts: pragmatism versus science.

Authors:  J J Earnshaw
Journal:  Eur J Vasc Endovasc Surg       Date:  2000-11       Impact factor: 7.069

2.  Preventing surgical site infections.

Authors:  Ronald Lee Nichols
Journal:  Clin Med Res       Date:  2004-05

Review 3.  Surgical hand preparation: state-of-the-art.

Authors:  A F Widmer; M Rotter; A Voss; P Nthumba; B Allegranzi; J Boyce; D Pittet
Journal:  J Hosp Infect       Date:  2009-08-28       Impact factor: 3.926

Review 4.  Practice guidelines for adult antibiotic prophylaxis during vascular and interventional radiology procedures. Written by the Standards of Practice Committee for the Society of Interventional Radiology and Endorsed by the Cardiovascular Interventional Radiological Society of Europe and Canadian Interventional Radiology Association [corrected].

Authors:  Aradhana M Venkatesan; Sanjoy Kundu; David Sacks; Michael J Wallace; Joan C Wojak; Steven C Rose; Timothy W I Clark; B Janne d'Othee; Maxim Itkin; Robert S Jones; Donald L Miller; Charles A Owens; Dheeraj K Rajan; Leann S Stokes; Timothy L Swan; Richard B Towbin; John F Cardella
Journal:  J Vasc Interv Radiol       Date:  2010-11       Impact factor: 3.464

5.  Antimicrobial silver grafts for prevention and treatment of vascular graft infection.

Authors:  Jean-Baptiste Ricco; Ojan Assadian
Journal:  Semin Vasc Surg       Date:  2011-12       Impact factor: 1.000

Review 6.  Management of patients with prosthetic vascular graft infection.

Authors:  J M Seeger
Journal:  Am Surg       Date:  2000-02       Impact factor: 0.688

Review 7.  New alternatives in management of the infected vascular prosthesis.

Authors:  S E Wilson
Journal:  Surg Infect (Larchmt)       Date:  2001       Impact factor: 2.150

8.  Are gram-negative bacteria a contraindication to selective preservation of infected prosthetic arterial grafts?

Authors:  K D Calligaro; F J Veith; M L Schwartz; R P Savarese; D A DeLaurentis
Journal:  J Vasc Surg       Date:  1992-09       Impact factor: 4.268

Review 9.  Intranasal mupirocin for reduction of Staphylococcus aureus infections in surgical patients with nasal carriage: a systematic review.

Authors:  Miranda M L van Rijen; Marc Bonten; Richard P Wenzel; Jan A J W Kluytmans
Journal:  J Antimicrob Chemother       Date:  2008-01-03       Impact factor: 5.790

10.  Incidence and clinical implication of nosocomial infections associated with implantable biomaterials - catheters, ventilator-associated pneumonia, urinary tract infections.

Authors:  Josef Peter Guggenbichler; Ojan Assadian; Michael Boeswald; Axel Kramer
Journal:  GMS Krankenhhyg Interdiszip       Date:  2011-12-15
View more
  2 in total

Review 1.  [Summary of the S3 guideline on abdominal aortic aneurysm from an anesthesiological perspective].

Authors:  A Funk; A Walther
Journal:  Anaesthesist       Date:  2020-01       Impact factor: 1.041

2.  Increased Pathogen Identification in Vascular Graft Infections by the Combined Use of Tissue Cultures and 16S rRNA Gene Polymerase Chain Reaction.

Authors:  Evelyne Ajdler-Schaeffler; Alexandra U Scherrer; Peter M Keller; Alexia Anagnostopoulos; Michael Hofmann; Zoran Rancic; Annelies S Zinkernagel; Guido V Bloemberg; Barbara K Hasse
Journal:  Front Med (Lausanne)       Date:  2018-06-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.